TomEnterprise AB - Significant Ownership

Signature - Title
/s/ Per Colleen - Chief Executive Officer
Location
Stockholm, Sweden
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by TomEnterprise AB.

Significant Ownership of TomEnterprise AB

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
DMAC DiaMedica Therapeutics Inc. Common Shares, no par value 16.28% $30.9M 8.38M TomEnterprise AB Jul 23, 2025

Schedules 13D/G Reported by TomEnterprise AB:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.